Key terms
About MRNA/
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MRNA/ news
No recent TipRanks articles are available for MRNA/
No recent press releases are available for MRNA/
MRNA/ Financials
Key terms
Ad Feedback
MRNA/ Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MRNA/ Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range